Imatinib mesylate tablets
Imatinib Mesylate is a drug commonly used to treat chronic myeloid leukemia (Chronic Myeloid Leukemia, CML) and some other leukemia and tumor types. It is a targeted therapy drug that interferes with the growth and division of leukemia cells by inhibiting specific protein kinases.
Here are some key information about imatinib mesylate:
1.Uses: Mainly used to treat CML, a specific type of leukemia, and some neurogenic tumors (such as gastrointestinal stromal tumors, Gastrointestinal Stromal Tumors, GISTs).
2.Working principle: Imatinib mesylate inhibits the activity of myeloid cell kinase (BCR-ABLkinase), thereby preventing the growth and division of abnormal leukemia cells. It may also be used to treat other diseases involving specific protein kinases.

3.Usage: Usually taken in the form of oral tablets, the dosage and medication plan are determined according to the doctor's prescription and the specific condition.
4.Side effects: Imatinib mesylate may cause some side effects, including nausea, vomiting, fatigue, edema, muscle pain, skin rash, etc. However, the severity of side effects varies between individuals and is usually manageable.
5.Treatment period: The treatment period is usually determined by the doctor and can be long-term. Patients usually need regular monitoring and follow-up with their doctor.
Imatinib was launched in China as early as2003. The domestic medical insurance price is about 700 yuan, and the specification is 100mg*60, since medical insurance varies greatly from place to place, so please consult your local pharmacy or medical insurance bureau for specific prices. Foreign medicines are divided into original drugs and generic drugs. Original drugs are mainly Turkish original drugs, and the price is relatively high, about 3300 yuan; generic drugs are mainly Indian generic drugs, and the Indian generic drugs specifications 100mg*120 are priced at around a few hundred yuan, which is much cheaper than domestic ones. The ingredients of foreign original drugs and generic drugs are basically the same as those of domestic imatinib.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)